Supplementary Table 3 from A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors
Year: 2023
Type: supplementary-materials
Abstract: Drug exposure for paclitaxel and pazopanib
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362526742